NDAORALTABLET
Approved
Jan 2023
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
5/8 — Partial
BRENZAVVY (bexagliflozin) by TheracosBio is sodium-glucose transporter 2 inhibitors [moa]. Approved for sodium-glucose cotransporter 2 inhibitor [epc]. First approved in 2023.
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BRENZAVVY (bexagliflozin) is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor approved in January 2023 for type 2 diabetes management. It works by blocking renal glucose reabsorption, promoting urinary glucose excretion and lowering blood glucose levels. The drug targets patients with type 2 diabetes seeking glycemic control with a novel mechanism of action.
Peak6.0 years to LOE
Recent peak-stage product with limited current commercial spending data; team composition and growth trajectory remain early indicators of sponsor commitment.
Mechanism of Action
Sodium-Glucose Transporter 2 Inhibitors
Pharmacologic Class:
Sodium-Glucose Cotransporter 2 Inhibitor
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on BRENZAVVY presents a career opportunity in a mature therapeutic class requiring competitive positioning and payer negotiation expertise. Limited current headcount signals a lean team model typical of late-entrant products competing against dominant players.
Brand ManagerMedical Science Liaison (MSL)
Worked on BRENZAVVY at TheracosBio? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.